{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:04:24Z","timestamp":1790802264578,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007107.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000}}],"reference-count":134,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007107.pub3","type":"journal-article","created":{"date-parts":[[2015,12,20]],"date-time":"2015-12-20T23:06:25Z","timestamp":1450652785000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy"],"prefix":"10.1002","volume":"2015","author":[{"given":"Nicole","family":"Skoetz","sequence":"first","affiliation":[{"name":"University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50937"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bohlius","sequence":"additional","affiliation":[{"name":"University of Bern; Institute of Social and Preventive Medicine; Finkenhubelweg 11 Bern Switzerland 3012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Monsef","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50937"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Blank","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50937"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg-Janne","family":"Vehreschild","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD007107.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/43.5.741","article-title":"Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B","volume":"43","author":"Schroder","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1054\/bjoc.2001.2114","article-title":"A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics","volume":"85","author":"Sculier","year":"2001","journal-title":"British Journal of Cancer"},{"issue":"34","key":"10.1002\/14651858.CD007107.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1200\/JCO.2012.44.6229.","article-title":"Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia","volume":"31","author":"Aarts","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00043426-200211000-00006","article-title":"Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group","volume":"24","author":"Alonzo","year":"2002","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0005|cit5","unstructured":"Altman A Steinherz P Trigg M Halpern S Jhanwar S Pieters R A prospective randomized trial of granulocyte colony-stimulating factor (G-CSF) during induction or consolidation phases of intensive chemotherapy for acute lymphocytic leukemia (ALL) [abstract] Journal of Clinical Oncology 1996 542, Abstract 1760"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/bjc.1994.71","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer","volume":"69","author":"Ardizzoni","year":"1994","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD007107.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1200\/JCO.1991.9.5.865","article-title":"Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial","volume":"9","author":"Attal","year":"1991","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1081\/CNV-100104288","article-title":"Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical trial","volume":"19","author":"Bennett","year":"2001","journal-title":"Cancer Investigation"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1182\/blood.V96.1.80","article-title":"A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation","volume":"96","author":"Bishop","year":"2000","journal-title":"Blood"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0010|cit10","unstructured":"Bj\u00f6rkholm M Osby E Hagberg H Kvaloy S Teerenhovi L Myhre J Randomized trial of r-metHu granulocyte colony-stimulating factor (G-CSF) as adjunct to CHOP or CNOP treatment of elderly patients with aggressive non-Hodgkin's lymphoma [abstract] Blood 1999 599a"},{"issue":"9","key":"10.1002\/14651858.CD007107.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.leu.2402218","article-title":"Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia","volume":"15","author":"Bradstock","year":"2001","journal-title":"Leukemia"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.critrevonc.2009.05.002","article-title":"Neutrophil recovery in elderly breast cancer patients receiving adjuvant anthracycline-containing chemotherapy with pegfilgrastim support","volume":"72","author":"Brugger","year":"2009","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/sj.bjc.6602975","article-title":"A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma","volume":"94","author":"Burton","year":"2006","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/gyno.1997.4630","article-title":"Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial","volume":"65","author":"Carlson","year":"1997","journal-title":"Gynecologic Oncology"},{"issue":"7","key":"10.1002\/14651858.CD007107.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.1995.13.7.1564","article-title":"Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer","volume":"13","author":"Chevallier","year":"1995","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD007107.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<331::AID-MPO4>3.0.CO;2-M","article-title":"Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia","volume":"32","author":"Clarke","year":"1999","journal-title":"Medical & Pediatric Oncology"},{"issue":"11","key":"10.1002\/14651858.CD007107.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1023\/A:1008271804151","article-title":"The impact of filgrastim schedule variation on hematopoietic recovery post-chemotherapy","volume":"8","author":"Crawford","year":"1997","journal-title":"Annals of Oncology"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJMoa050078","article-title":"Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas","volume":"353","author":"Cullen","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0609.1995.tb01816.x","article-title":"Assessment of the value of treatment with granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial","volume":"55","author":"Dibenedetto","year":"1995","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0020|cit20","first-page":"S519","article-title":"Randomised, placebo-controlled phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: The APRONTA Trial","volume":"15","author":"Dickgreber","year":"2009","journal-title":"[19th European Congress of Clinical Microbiology and Infectious Diseases]. Clinical Microbiology and Infection"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0609.2005.00438.x","article-title":"Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy","volume":"75","author":"Doorduijn","year":"2005","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0022|cit22","unstructured":"Dunlop DJ Andersen S Paul J Soukop M Ellis D Tansey P Filgrastim as an adjunct to combination chemotherapy in Hodgkin's disease Annals of Oncology 1996 51"},{"issue":"11","key":"10.1002\/14651858.CD007107.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ajh.21855","article-title":"Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial","volume":"85","author":"Eleutherakis-Papaiakovou","year":"2010","journal-title":"American Journal of Hematology"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1753-5174.2008.00013.x","article-title":"A phase 3, randomized, placebo-controlled trial of filgrastim in patients with haematological malignancies undergoing matched-related allogeneic bone marrow transplantation","volume":"1","author":"Ernst","year":"2008","journal-title":"Archives of Drug Information"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1600-0609.2006.00741.x","article-title":"Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial","volume":"77","author":"Faber","year":"2006","journal-title":"European Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000356626","article-title":"Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia","volume":"132","author":"Feng","year":"2014","journal-title":"Acta Haematologica"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s002770050330","article-title":"Randomized open label phase III trial of CEOP\/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP\/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor Therapy.[Erratum appears in Ann Hematol. 2014 Mar;93(3):539-40]","volume":"75","author":"Fridrik","year":"1997","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0028|cit28","unstructured":"Garcia G Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: Results of a randomized study Revista Espanola de Quimioterapia 2000 257 63"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0029|cit29","first-page":"257","article-title":"Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study","volume":"15","author":"Garcia-Saenz","year":"2002","journal-title":"Revista Espanola de Quimioterapia"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/blood.V90.2.590","article-title":"Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study","volume":"90","author":"Geissler","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1182\/blood.V91.10.3607","article-title":"A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031)","volume":"91","author":"Godwin","year":"1998","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/sj.bmt.1704699","article-title":"A prospective randomized study of clinical and economic consequences of using G-CSF following autologous peripheral blood progenitor cell (PBPC) transplantation in children","volume":"34","author":"Gonzalez-Vicent","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0033|cit33","first-page":"1057","article-title":"GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation","volume":"18","author":"Greenberg","year":"1996","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-116-3-177","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease","volume":"116","author":"Gulati","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"25","key":"10.1002\/14651858.CD007107.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJM199706193362502","article-title":"Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia","volume":"336","author":"Hartmann","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1200\/JCO.2003.07.129","article-title":"Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study","volume":"21","author":"Heath","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3816\/CCC.2010.n.013","article-title":"A randomized, placebo-controlled phase II study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy","volume":"9","author":"Hecht","year":"2010","journal-title":"Clinical Colorectal Cancer"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1182\/blood.V90.12.4710","article-title":"A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group","volume":"90","author":"Heil","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/10428190290006099","article-title":"G-CSF administered in time-sequenced setting during remission induction and consolidation therapy of adult acute lymphoblastic leukemia has beneficial influence on early recovery and possibly improves long-term outcome: a randomized multicenter study","volume":"43","author":"Holowiecki","year":"2002","journal-title":"Leukemia & Lymphoma"},{"issue":"11","key":"10.1002\/14651858.CD007107.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1200\/JCO.1996.14.11.2976","article-title":"Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer","volume":"14","author":"Jones","year":"1996","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/14653240310003648","article-title":"Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study","volume":"5","author":"Joshi","year":"2003","journal-title":"Cytotherapy"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0042|cit42","first-page":"66","article-title":"Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract","volume":"48","author":"Karp","year":"1986","journal-title":"Scandinavian Journal of Infectious Diseases Supplement"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Kim S Cho YH Ko OB Koo JE Lee D Chong YP Beneficial prophylactic antimicrobial use against infectious complications during autologous stem cell transplantation: a result of randomized phase II study in multiple myeloma and non-Hodgkin's lymphoma patients Blood 2005","DOI":"10.1182\/blood.V106.11.5477.5477"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00520-014-2597-1","article-title":"Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel\/cyclophosphamide chemotherapy","volume":"23","author":"Kosaka","year":"2015","journal-title":"Support Care Cancer"},{"issue":"21","key":"10.1002\/14651858.CD007107.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1200\/JCO.2009.27.3524","article-title":"Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1\/SIOPEN study","volume":"28","author":"Ladenstein","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00520-004-0658-6","article-title":"A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia","volume":"12","author":"Lalami","year":"2004","journal-title":"Supportive Care in Cancer"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000204389","article-title":"Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients","volume":"90","author":"Lamy","year":"1993","journal-title":"Acta Haematologica"},{"issue":"5","key":"10.1002\/14651858.CD007107.pub3-BIB0048|cit48","first-page":"1556","article-title":"A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111","volume":"92","author":"Larson","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/bjc.1998.216","article-title":"Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost","volume":"77","author":"Lee","year":"1998","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3904\/kjim.2002.17.1.38","article-title":"Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial","volume":"17","author":"Lee","year":"2002","journal-title":"Korean Journal of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood-2006-07-035915","article-title":"Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia","volume":"109","author":"Lehrnbecher","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/mpo.1279","article-title":"A randomised study of prophylactic G-CSF following MRC UKALL XI intensification regimen in childhood ALL and T-NHL","volume":"38","author":"Little","year":"2002","journal-title":"Medical & Pediatric Oncology"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0959-8049(93)90011-4","article-title":"Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients","volume":"29A","author":"Maiche","year":"1993","journal-title":"European Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1200\/JCO.1997.15.2.451","article-title":"Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit (Structured abstract)","volume":"15","author":"McQuaker","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD007107.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1200\/JCO.2000.18.7.1517","article-title":"Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia","volume":"18","author":"Michel","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD007107.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0959-8049(98)00061-6","article-title":"An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma","volume":"34","author":"Michon","year":"1998","journal-title":"European Journal of Cancer"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1200\/JCO.1994.12.1.77","article-title":"Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer","volume":"12","author":"Miles","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0058|cit58","first-page":"949","article-title":"Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation","volume":"15","author":"Nemunaitis","year":"1995","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007107.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2141.2007.06587.x","article-title":"Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue","volume":"137","author":"Nolan","year":"2007","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.bmt.1701972","article-title":"A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults","volume":"24","author":"Ojeda","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1182\/blood-2002-10-3238","article-title":"CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial","volume":"101","author":"Osby","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood.V86.2.444.bloodjournal862444","article-title":"Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial","volume":"86","author":"Ottmann","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0063|cit63","first-page":"441","article-title":"Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology","volume":"20","author":"Patte","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01650752","article-title":"The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study","volume":"16","author":"Petersen","year":"1988","journal-title":"Infection"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood.V80.6.1430.1430","article-title":"Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial","volume":"80","author":"Pettengell","year":"1992","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.bmt.1701795","article-title":"Optimal timing of G-CSF administration after CD34+ immunoselected peripheral blood progenitor cell transplantation","volume":"23","author":"Piccirillo","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub3-BIB0067|cit67","first-page":"249","article-title":"Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patients","volume":"32","author":"Pignon","year":"1990","journal-title":"Nouvelle Revue Fran\u00e7aise d'H\u00e9matologie"},{"issue":"11","key":"10.1002\/14651858.CD007107.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood.V97.11.3405","article-title":"Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors","volume":"97","author":"Przepiorka","year":"2001","journal-title":"Blood"},{"issue":"25","key":"10.1002\/14651858.CD007107.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199706193362503","article-title":"Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia","volume":"336","author":"Pui","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0070|cit70","first-page":"174","article-title":"Oral ciprofloxacin in the prophylaxis of bacterial infection in neutropenic patients. A randomized, double-blind, comparative clinical study","volume":"2","author":"Rafecas","year":"1989","journal-title":"Revista Espa\u00f1ola de Quimioterapia"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.critrevonc.2006.12.007","article-title":"Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial","volume":"64","author":"Romieu","year":"2007","journal-title":"Critical Reviews in Oncology\/hematology"},{"issue":"11","key":"10.1002\/14651858.CD007107.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bmt.1704724","article-title":"Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial","volume":"34","author":"Schmitz","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1097\/JTO.0b013e3182307e3c","article-title":"Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial","volume":"6","author":"Schuette","year":"2011","journal-title":"Journal of Thoracic Oncology"},{"issue":"13-14","key":"10.1002\/14651858.CD007107.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/0959-8049(95)00197-2","article-title":"A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma","volume":"31A","author":"Seymour","year":"1995","journal-title":"European Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.1994.12.4.661","article-title":"Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit","volume":"12","author":"Spitzer","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD007107.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1200\/JCO.1994.12.9.1931","article-title":"Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies","volume":"12","author":"Stahel","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"15S","key":"10.1002\/14651858.CD007107.pub3-BIB0077|cit77","first-page":"81","article-title":"Prevention of infection after TAC chemotherapy for node-positive breast cancer as an adjuvant therapy with or without ciprofloxacin","volume":"26","author":"Suh","year":"2008","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/AAC.37.3.474","article-title":"Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group","volume":"37","author":"Talbot","year":"1993","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"31","key":"10.1002\/14651858.CD007107.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1200\/JCO.2004.00.7955","article-title":"Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study","volume":"23","author":"Timmer-Bonte","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/annonc\/mdg073","article-title":"Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)","volume":"14","author":"Tjan-Heijnen","year":"2003","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1399-3046.2000.00101.x","article-title":"Administration of recombinant human granulocyte-macrophage colony-stimulating factor to children undergoing allogeneic marrow transplantation: a prospective, randomized, double-masked, placebo-controlled trial","volume":"4","author":"Trigg","year":"2000","journal-title":"Pediatric Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0959-8049(93)90376-Q","article-title":"Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy","volume":"29A","author":"Trillet-Lenoir","year":"1993","journal-title":"European Journal of Cancer"},{"issue":"11","key":"10.1002\/14651858.CD007107.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/cncr.22227","article-title":"Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial","volume":"107","author":"Veyret","year":"2006","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2005.09.102","article-title":"First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study","volume":"23","author":"Vogel","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1182\/blood.V87.8.3143.bloodjournal8783143","article-title":"A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Munster Study Group","volume":"87","author":"Welte","year":"1996","journal-title":"Blood"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub3-BIB0086|cit86","first-page":"2722","article-title":"A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM)","volume":"91","author":"Witz","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1002\/14651858.CD007107.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2169\/internalmedicine.32.710","article-title":"Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B","volume":"32","author":"Yamada","year":"1993","journal-title":"Internal Medicine (Tokyo, Japan)"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<289::AID-AJH7>3.0.CO;2-S","article-title":"Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin","volume":"51","author":"Yau","year":"1996","journal-title":"American Journal of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0089|cit89","first-page":"77","article-title":"Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF","volume":"51","author":"Alvarado Ibarra","year":"1999","journal-title":"Revista de Investigacion Clinica"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/PL00009894","article-title":"Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy","volume":"5","author":"Beveridge","year":"1997","journal-title":"Supportive Care in Cancer"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/07357909809115775","article-title":"A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression","volume":"16","author":"Beveridge","year":"1998","journal-title":"Cancer Investigation"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Annals of Internal Medicine"},{"issue":"1A","key":"10.1002\/14651858.CD007107.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(86)90510-3","article-title":"Infection in cancer patients. A continuing association","volume":"81","author":"Bodey","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub3-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003189.pub4","article-title":"Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma","author":"Bohlius","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/bjc.1988.163","article-title":"In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients","volume":"58","author":"Bronchud","year":"1988","journal-title":"British Journal of Cancer"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/clinids\/20.3.557","article-title":"Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin","volume":"20","author":"Carratala","year":"1995","journal-title":"Clinical Infectious Diseases"},{"issue":"18","key":"10.1002\/14651858.CD007107.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.2005.05.645","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials","volume":"23","author":"Clark","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199107183250305","article-title":"Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer","volume":"325","author":"Crawford","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"22","key":"10.1002\/14651858.CD007107.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2003.01.234","article-title":"Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients","volume":"21","author":"Cruciani","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0101|cit101","article-title":"Chapter 9: Analysing data and undertaking meta-analyses","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011].The Cochrane Collaboration. Available from www.cochrane-handbook.org","author":"Deeks","year":"2011"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1200\/JCO.1998.16.3.1179","article-title":"Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis","volume":"16","author":"Engels","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002770050487","article-title":"G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers: comparison of efficacy and tolerability","volume":"78","author":"Fischmeister","year":"1999","journal-title":"Annals of Hematology"},{"issue":"12 Pt 1","key":"10.1002\/14651858.CD007107.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-Analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkl425","article-title":"Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis","volume":"59","author":"Gafter-Gvili","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004386.pub3","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/stem.5530080705","article-title":"The biology of GM-CSF: regulation of production and interaction with its receptor","volume":"8 Suppl 1","author":"Griffin","year":"1990","journal-title":"International Journal of Cell Cloning"},{"issue":"7","key":"10.1002\/14651858.CD007107.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.bjc.6601708","article-title":"Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?","volume":"90","author":"Hackshaw","year":"2004","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0109|cit109","article-title":"Chapter 7: Selecting studies and collecting data","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0110|cit110","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0111|cit111","article-title":"Chapter 16: Special topics in statistics","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011].The Cochrane Collaboration. Available from www.cochrane-handbook.org","author":"Higgins","year":"2011"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/annonc\/mdf130","article-title":"Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer","volume":"13","author":"Holmes","year":"2002","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.1992.10.3.390","article-title":"Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I\/II study","volume":"10","author":"Hovgaard","year":"1992","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"10.1002\/14651858.CD007107.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2000.18.13.2522","article-title":"Randomized, dose-escalation study of SD\/01 compared with daily filgrastim in patients receiving chemotherapy","volume":"18","author":"Johnston","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-106-1-1","article-title":"Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial","volume":"106","author":"Karp","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0117|cit117","article-title":"Chapter 6: Searching for studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, Available from www.cochrane-handbook.org","author":"Lefebvre","year":"2011"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.22205","article-title":"Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions","volume":"107","author":"Leibovici","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JCO.1995.13.1.239","article-title":"Ciprofloxacin versus trimethoprim\/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial","volume":"13","author":"Lew","year":"1995","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD007107.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0002-9343(02)01036-7","article-title":"Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: A meta-analysis","volume":"112","author":"Lyman","year":"2002","journal-title":"American Journal of Medicine"},{"issue":"17","key":"10.1002\/14651858.CD007107.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1200\/JCO.2009.25.8723","article-title":"Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review","volume":"28","author":"Lyman","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8587","key":"10.1002\/14651858.CD007107.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(88)91475-4","article-title":"Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy","volume":"1","author":"Morstyn","year":"1988","journal-title":"Lancet"},{"issue":"24","key":"10.1002\/14651858.CD007107.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM199909163411207","article-title":"Fever in immunocompromised patients","volume":"341","author":"Pizzo","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0126|cit126","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"28","key":"10.1002\/14651858.CD007107.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"33","author":"Smith","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD007107.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/jac\/30.5.730","article-title":"Superinfections by Escherichia coli resistant to fluoroquinolones in immunocompromised patients","volume":"30","author":"Somolinos","year":"1992","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD007107.pub3-BIB0129|cit129","article-title":"Chapter 10: Addressing reporting biases","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, Available from www.cochrane-handbook.org.","author":"Sterne","year":"2011"},{"issue":"16","key":"10.1002\/14651858.CD007107.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2004.09.106","article-title":"Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: A meta-analysis of randomized controlled trials","volume":"22","author":"Sung","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-147-6-200709180-00010","article-title":"Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection","volume":"147","author":"Sung","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"June 7","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"9","key":"10.1002\/14651858.CD007107.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/annonc\/mdu035","article-title":"Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO)","volume":"25","author":"Vehreschild","year":"2014","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ctrv.2006.03.002","article-title":"Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials","volume":"32","author":"Wittman","year":"2006","journal-title":"Cancer Treatment Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007107.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T05:48:30Z","timestamp":1645076910000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007107.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":134,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007107.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,21]]}}}